000028 China National Accord Medicines Corporation
- 32.25
- +1.78+5.84%
China National Accord Medicines Corporation News
China National Accord Medicines Corporation: Announcement of the implementation of equity distribution in 2023.
Sinopharm\'s agreement: announcement on the 2023 profit distribution plan
Sinopharm: 2022 Equity Distribution Implementation Notice
Sinopharm Consistent: Announcement on 2022 Profit Distribution and Capital Transfer Plan from Capital Provident Fund
Sinopharm: 2020 Equity Distribution Implementation Notice
Sinopharm: 2019 Profit Distribution Implementation Notice
Sinopharm: An indicative announcement on the lifting of the restrictions on the sale of restricted shares on the non-public offering of shares
Sinopharm: 2018 Profit Distribution Implementation Notice
Sinopharm: 2017 Profit Distribution Implementation Notice
Sinopharm: 2016 Annual Equity Distribution Implementation Notice
Sinopharm is consistent: Announcement on asset sales, issuance of shares, payment of cash to purchase assets and raising supporting funds, and fulfillment of commitments issued by parties involved in related transactions
Sinopharm: An indicative announcement on the lifting of the restrictions on the sale of restricted shares on the non-public offering of shares
Sinopharm Consistent: Asset Sales, Issuance of Shares, Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Transactions and Implementation of Additional Stock Listing Announcements (Summary)
Sinopharm is consistent: implementation of asset sales, issuance of shares, payment of cash to purchase assets and raise supporting capital and related transactions, and listing announcements of additional shares
Sinopharm is consistent: Announcement on asset sales, issuance of shares, payment of cash to purchase assets and raising supporting funds and issuing commitments by parties involved in related transactions
Sinopharm Consistent: Report on Asset Sales, Issuance of Shares, and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Transactions (Revised Draft)
Sinopharm Consistent: Summary of the Report on Asset Sales, Issuance of Shares, and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Transactions (Revised Draft)
Sinopharm Consistent: Notice on Revised Instructions for Asset Sales, Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Transactions and Restructuring Reports
Sinopharm agreed: Announcement on asset sales, issuance of shares, and payment of cash to purchase assets and raise supporting funds and related transactions was officially approved by the China Securities Regulatory Commission
Sinopharm Consistent: Report on Asset Sales, Issuance of Shares, and Payment of Cash to Purchase Assets and Raise Supporting Funds and Related Transactions (Draft) (Three Revisions)
Analysis
Price Target
No Data
No Data